Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 29% ± 16% | |
| adipocyte | 9 studies | 36% ± 14% | |
| astrocyte | 8 studies | 29% ± 12% | |
| retinal ganglion cell | 6 studies | 43% ± 20% | |
| epithelial cell | 6 studies | 36% ± 21% | |
| fibroblast | 6 studies | 22% ± 10% | |
| oligodendrocyte | 6 studies | 26% ± 7% | |
| glutamatergic neuron | 5 studies | 45% ± 23% | |
| microglial cell | 5 studies | 20% ± 4% | |
| OFF-bipolar cell | 5 studies | 35% ± 14% | |
| retina horizontal cell | 5 studies | 23% ± 3% | |
| retinal rod cell | 5 studies | 22% ± 4% | |
| cardiac muscle cell | 5 studies | 32% ± 9% | |
| ciliated cell | 5 studies | 20% ± 2% | |
| classical monocyte | 4 studies | 21% ± 4% | |
| retinal bipolar neuron | 4 studies | 51% ± 11% | |
| ON-bipolar cell | 4 studies | 34% ± 11% | |
| myeloid cell | 4 studies | 17% ± 1% | |
| amacrine cell | 4 studies | 21% ± 3% | |
| Mueller cell | 4 studies | 22% ± 4% | |
| GABAergic neuron | 4 studies | 43% ± 18% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 7% | |
| monocyte | 4 studies | 18% ± 3% | |
| type I pneumocyte | 4 studies | 19% ± 3% | |
| interneuron | 4 studies | 33% ± 19% | |
| pancreatic A cell | 3 studies | 28% ± 8% | |
| hematopoietic precursor cell | 3 studies | 21% ± 4% | |
| non-classical monocyte | 3 studies | 22% ± 7% | |
| rod bipolar cell | 3 studies | 60% ± 5% | |
| abnormal cell | 3 studies | 22% ± 8% | |
| hepatocyte | 3 studies | 35% ± 17% | |
| basal cell | 3 studies | 46% ± 29% | |
| goblet cell | 3 studies | 29% ± 13% | |
| transit amplifying cell | 3 studies | 43% ± 38% | |
| neuron | 3 studies | 27% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3775.54 | 1445 / 1445 | 100% | 29.75 | 183 / 183 |
| prostate | 100% | 2597.73 | 245 / 245 | 100% | 32.84 | 502 / 502 |
| skin | 100% | 3822.63 | 1809 / 1809 | 100% | 49.97 | 472 / 472 |
| breast | 100% | 3670.16 | 459 / 459 | 100% | 32.65 | 1117 / 1118 |
| kidney | 100% | 3649.02 | 89 / 89 | 100% | 34.59 | 899 / 901 |
| brain | 100% | 2559.13 | 2636 / 2642 | 100% | 35.16 | 705 / 705 |
| stomach | 100% | 2242.86 | 359 / 359 | 100% | 21.16 | 285 / 286 |
| intestine | 100% | 3210.59 | 966 / 966 | 100% | 22.08 | 525 / 527 |
| bladder | 100% | 3304.19 | 21 / 21 | 100% | 23.66 | 502 / 504 |
| lung | 100% | 2563.52 | 576 / 578 | 100% | 30.62 | 1154 / 1155 |
| ovary | 100% | 2094.29 | 180 / 180 | 100% | 16.88 | 428 / 430 |
| thymus | 100% | 2401.79 | 652 / 653 | 100% | 27.92 | 603 / 605 |
| uterus | 100% | 2139.47 | 170 / 170 | 99% | 23.05 | 456 / 459 |
| liver | 100% | 2088.18 | 225 / 226 | 100% | 19.93 | 405 / 406 |
| adrenal gland | 100% | 5468.71 | 258 / 258 | 99% | 32.75 | 228 / 230 |
| pancreas | 99% | 1897.84 | 325 / 328 | 99% | 21.80 | 177 / 178 |
| adipose | 100% | 4139.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2472.07 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 60.70 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 21.10 | 29 / 29 |
| muscle | 100% | 10173.74 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2031.41 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 30.57 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 13.35 | 1 / 1 |
| heart | 97% | 3507.95 | 831 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 1799.01 | 892 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006915 | Biological process | apoptotic process |
| GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO_0042981 | Biological process | regulation of apoptotic process |
| GO_0031966 | Cellular component | mitochondrial membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
| GO_0005515 | Molecular function | protein binding |
| Gene name | BCL2L13 |
| Protein name | BCL2-like 13 (Apoptosis facilitator), isoform CRA_c (cDNA, FLJ95299, highly similar to Homo sapiens BCL2-like 13 (apoptosis facilitator) (BCL2L13),nuclear gene encoding mitochondrial protein, mRNA) Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1) BCL2 like 13 |
| Synonyms | MIL1 hCG_19914 CD003 |
| Description | FUNCTION: May promote the activation of caspase-3 and apoptosis. |
| Accessions | ENST00000543133.5 [Q9BXK5-4] ENST00000498133.5 A0A087WX97 F6VJB4 ENST00000317582.10 [Q9BXK5-1] ENST00000418951.6 [Q9BXK5-4] ENST00000399777.1 ENST00000616863.4 ENST00000337612.9 E9PDD6 ENST00000399782.5 [Q9BXK5-2] F2Z2C3 ENST00000355028.4 ENST00000538149.5 ENST00000611738.4 B2RB43 ENST00000618481.4 ENST00000493680.5 [Q9BXK5-2] H0Y3R5 A0A0A0MR90 A0A087WW80 Q9BXK5 A0A087WTL4 |